Details
Manufacturer
Hovid Berhad, Malaysia.
Registraction Number
MAL09011430AZ
Hovid Berhad, Malaysia.
Registraction Number
MAL09011430AZ
Content
-
Active Ingredients: Each film-coated tablet contains 5 mg Glibenclamide and 500 mg Metformin Hydrochloride, combining a sulfonylurea and a biguanide to manage type 2 diabetes mellitus.
-
Formulation: The tablet is oblong and yellow, with shallow convex faces, "HD" embossed, and scored on the same face.
Indications
-
Treatment of Type 2 Diabetes Mellitus in adults, particularly in overweight patients, when dietary management and exercise alone do not result in adequate glycaemic control.
-
Monotherapy or Combination Therapy: Diamide 5mg/500mg may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.
-
Dual Action: Glibenclamide stimulates insulin secretion, while Metformin enhances insulin sensitivity and reduces hepatic glucose production.
Instructions for Use
-
Administration: For oral use only. Swallow the tablet whole with water; do not chew, crush, or split the tablet.
-
Dosage: The usual starting dose is 5 mg Glibenclamide and 500 mg Metformin taken 2 or 3 times daily during or after meals.
-
Maximum Dose: The maximum recommended dose is 10 mg Glibenclamide and 1,000 mg Metformin daily, taken as 2 or 3 divided doses.
View more about Hovid Diamide 5mg/500mg Tab on main site